首页> 外国专利> IN-VITRO METHOD FOR MONOCLONAL ANTIBODY PRODUCTION USING NON-HUMAN ACT1 -DEFICIENT MICE

IN-VITRO METHOD FOR MONOCLONAL ANTIBODY PRODUCTION USING NON-HUMAN ACT1 -DEFICIENT MICE

机译:使用非人类ACT1缺陷小鼠生产单克隆抗体的体外方法

摘要

A method of producing an IgG type monoclonal antibody in vitro is described. The method includes the steps of: (A) providing B-cells obtained from a transgenic non-human mammal whose genome comprises a disruption of an Act1 gene; (B) contacting the B cells with an antigen under conditions which result in formation of an antibody specific to the antigen by the B cells; (C) fusing the B cells with one or more immortal cells, to produce one or more hybridomas which express IgG type monoclonal antibodies that specifically bind to the antigen; (D) selecting a hybridoma which expresses an antibody specific to the antigen; and (E) obtaining monoclonal antibody produced by the selected hybridoma. Kits for carrying out the method of producing an IgG type monoclonal antibody are also described.
机译:描述了一种在体外产生IgG型单克隆抗体的方法。该方法包括以下步骤:(A)提供从转基因非人类哺乳动物中获得的B细胞,其基因组包含Act1基因的破坏; (B)在导致B细胞形成对该抗原特异性的抗体的条件下使B细胞与抗原接触; (C)将B细胞与一种或多种永生细胞融合,以产生一种或多种表达特异性结合抗原的IgG型单克隆抗体的杂交瘤; (D)选择表达对抗原特异的抗体的杂交瘤; (E)获得由所选择的杂交瘤产生的单克隆抗体。还描述了用于进行产生IgG型单克隆抗体的方法的试剂盒。

著录项

  • 公开/公告号WO2014144170A1

    专利类型

  • 公开/公告日2014-09-18

    原文格式PDF

  • 申请/专利权人 THE CLEVELAND CLINIC FOUNDATION;

    申请/专利号WO2014US28464

  • 发明设计人 POPTIC EARL J.;LI XIAOXIA;

    申请日2014-03-14

  • 分类号C07K16;C07K16/46;

  • 国家 WO

  • 入库时间 2022-08-21 15:47:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号